HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,465-1,476 of 7,264
Device study icon
TerminatedNCT06682299

Maintenance TMS in Treatment Resistant Depression

Official study title

Transitioning From Maintenance ECT to Maintenance TMS in Treatment Resistant Depression

This study ended early.

In Lexington
DepressionDevice studyAges 18–65
Countries
United States
Sponsor
Austin Messner
Device study icon
CompletedNCT07274917

Stereotactic Radiotherapy Treatment for Treatment-Resistant Depression

Official study title

Safety and Efficacy of Low-Dose Stereotactic Radiotherapy Targeting the Subgenual Anterior Cingulate Cortex for Treatment-Resistant Depression: Study Protocol for a Dose-Exploratory, Parallel-Controlled Trial

This study has finished and is no longer accepting participants.

In Beijing
DepressionDevice studyAges 18–50
Countries
China
Sponsor
Capital Medical University
Drug study icon
CompletedNCT04979910

Targeting IL-17A for Treatment-Resistant Depression

Official study title

An Experimental Therapeutics Study of a Monoclonal Antibody Against Interleukin 17A in Patients With Treatment-Resistant Depression

This study has finished and is no longer accepting participants.

In New York
DepressionMedication studyAges 18–70
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Other study type icon
CompletedNCT03207282

Treatment Resistant Depression in America Latina

This study has finished and is no longer accepting participants.

Multiple locations, including Buenos Aires
DepressionObservational studyAges 18+
Countries
Argentina, Brazil, Colombia, + 1 other
Sponsor
Janssen-Cilag, S.A.
Other study type icon
CompletedNCT03373253

Treatment-Resistant Depression Cohort in Europe

This study has finished and is no longer accepting participants.

Multiple locations, including Bilzen
DepressionObservational studyAges 18–74
Countries
United Kingdom, Belgium, Germany, + 4 others
Sponsor
Janssen-Cilag Ltd.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.